Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,411 | 295 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,045 | 93 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $497.99 | 40 | $0 (2024) |
| Amgen Inc. | $455.62 | 27 | $0 (2024) |
| Merck Sharp & Dohme LLC | $366.75 | 18 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $286.39 | 19 | $0 (2024) |
| Abbott Laboratories | $282.05 | 13 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $238.49 | 16 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $207.47 | 11 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $195.67 | 11 | $0 (2024) |
| Esperion Therapeutics, Inc. | $187.65 | 9 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $926.66 | 60 | Novartis Pharmaceuticals Corporation ($200.68) |
| 2023 | $819.18 | 65 | Novartis Pharmaceuticals Corporation ($202.54) |
| 2022 | $1,237 | 73 | Novartis Pharmaceuticals Corporation ($340.67) |
| 2021 | $1,428 | 97 | Novartis Pharmaceuticals Corporation ($301.32) |
All Payment Transactions
295 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.12 | General |
| Category: DIABETES | ||||||
| 11/21/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/20/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Not Applicable | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $6.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/13/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/12/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $28.37 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/17/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $9.25 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $3.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/01/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Not Applicable | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/19/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Cardiology | ||||||
| 09/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $6.61 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $6.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $9.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $1.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/14/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $12.21 | General |
| Category: Cardiology | ||||||
| 08/13/2024 | ConvaTec Inc. | AQUACEL AG+ EXTRA (Device) | Food and Beverage | In-kind items and services | $30.15 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 07/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $1.17 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $1.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/26/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Not Applicable | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 85 | 85 | $10,850 | $5,203 |
| 2022 | 2 | 92 | 99 | $12,870 | $6,912 |
| 2021 | 2 | 95 | 106 | $14,450 | $7,714 |
| 2020 | 3 | 96 | 107 | $7,503 | $4,344 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 51 | 51 | $7,650 | $3,297 | 43.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 34 | 34 | $3,200 | $1,906 | 59.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 61 | 66 | $9,900 | $4,996 | 50.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 31 | 33 | $2,970 | $1,916 | 64.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 78 | 85 | $12,570 | $6,511 | 51.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 17 | 21 | $1,880 | $1,203 | 64.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 49 | 51 | $4,080 | $2,191 | 53.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 27 | 29 | $3,045 | $1,963 | 64.5% |
| 93793 | Anti-clotting management for patient taking warfarin | Office | 2020 | 20 | 27 | $378.00 | $190.85 | 50.5% |
About Caleb Elmore, NP-C
Caleb Elmore, NP-C is a Nurse Practitioner healthcare provider based in Tuscaloosa, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2014. The National Provider Identifier (NPI) number assigned to this provider is 1013322288.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Caleb Elmore, NP-C has received a total of $4,411 in payments from pharmaceutical and medical device companies, with $926.66 received in 2024. These payments were reported across 295 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($4,411).
As a Medicare-enrolled provider, Elmore has provided services to 368 Medicare beneficiaries, totaling 397 services with total Medicare billing of $24,173. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Tuscaloosa, AL
- Active Since 06/26/2014
- Last Updated 09/03/2014
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1013322288
Products in Payments
- ENTRESTO (Drug) $652.66
- XARELTO (Drug) $497.99
- Repatha (Biological) $455.62
- LEQVIO (Drug) $392.55
- VERQUVO (Drug) $338.38
- LifeVest (Device) $286.39
- Adempas (Drug) $207.22
- MULTAQ (Drug) $195.67
- NEXLETOL (Drug) $187.65
- FARXIGA (Drug) $124.74
- CardioMEMS HF System (Device) $114.14
- BRILINTA (Drug) $82.73
- Vascepa (Drug) $77.75
- Confirm Rx (Device) $77.51
- KENGREAL (Drug) $74.44
- Arcalyst (Drug) $61.71
- JARDIANCE (Drug) $57.99
- CARDIOMEMS (Device) $57.85
- ZIO XT Patch (Device) $56.13
- VYNDAMAX (Drug) $47.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Tuscaloosa
Mrs. Linda Canterbury, Crnp, CRNP
Nurse Practitioner — Payments: $7,593
Mr. James Fenley
Nurse Practitioner — Payments: $7,379
Mr. John Chambers, Crnp, CRNP
Nurse Practitioner — Payments: $6,223
Kimberley Carver, Crnp, CRNP
Nurse Practitioner — Payments: $5,478
Tyler Keenum, Crnp, CRNP
Nurse Practitioner — Payments: $3,595
Mr. Gregory Hamrick, Crnp, CRNP
Nurse Practitioner — Payments: $3,493